Pl
Plurilock
Tel Aviv ILFounded 201620 employees
Private CapbiotechPrivateOncology
Platform: Cyber Bio
Market Cap
N/A
All Drugs
4
Clinical Trials
7
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Tirazumab | PLU-3000 | Phase 2/3 | 2 | KIF18A | ADPKDAngelman | ||
| Kemavorutinib | PLU-8176 | Phase 2/3 | 2 | CDK2 | PVBreast Ca | ||
| PLU-3424 | PLU-3424 | Phase 2 | 2 | SHP2 | CMLACC | ||
| Lirazumab | PLU-2055 | Phase 1 | 1 | KRASG12D | ObesitySMA |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)